The recommendations come as four Indian drug companies, Cipla, Hetero,
Mylan and Jubilant, gear up to get an approval for the drug in the
treatment of Covid-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/remdesivir-use-may-be-managed-by-government/articleshow/76127218.cms
No comments:
Post a Comment